Beta-blockers have been the cornerstone of treatment for obstructive hypertrophic cardiomyopathy for almost 6 years. Recent ...
Hosted on MSN
Clinical trial finds aficamten is superior to metoprolol for symptomatic obstructive hypertrophic cardiomyopathy
Aficamten treatment was associated with significant improvements in exercise capacity and symptoms compared with metoprolol in patients with symptomatic obstructive hypertrophic cardiomyopathy (HCM), ...
Beta-blockers are widely prescribed pharmaceuticals used to manage cardiovascular conditions such as hypertension, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback